Caitong International Asset Management’s Corvus Pharmaceuticals CRVS Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$8.13K	Buy	2,032 +1,745	+608%	+$6.98K	0.01%	811
2025 Q1	$913	Buy	287 +267	+1,335%	+$849	﹤0.01%	1594
2024 Q4	$107	Buy	+20	New	+$107	﹤0.01%	1614